Objective: To assess the efficacy of encainide and flecainide in treating patients with sustained ventricular arrhythmias. Design: Patients were treated with encainide or flecainide. Effi-cacy was assessed by comparing the results of programmed ven-tricular stimulation while patients received therapy with the results while they were drug free. Setting: The electrophysiology laboratory of the University of California at San Francisco. Patients: Forty-nine patients with spontaneous or inducible sustained ventricular tachycardia or ventricular fibrillation for whom treatment with at least one class IA antiarrhythmic agent had failed. Interventions: Patients were treated with encainide, 35 to 50 mg three or four times daily, or flecainide, 100 ...
Over the last 35 years, flecainide proved itself one of the most commonly used arrhythmic drugs, exp...
AbstractThirty-eight patients who had inducible sustained ventricular tachycardia during baseline pr...
SUMMARY In a previous clinical study we demonstrated that tocainide is effective in the suppression ...
Flecainide has demonstrated unsurpassed antiarrhythmic activity in patients with stable ventricular ...
AbstractThe potential for proarrhythmic responses to the class IC sodium channel-blocking drugs enca...
Thirty-eight patients with organic heart disease and history of sudden cardiac arrest or recurrent s...
In the treatment of chronic ectopic atrial tachycardia, standard antiarrhythmic therapy has been sho...
Effective antiarrhythmic therapy requires a carefully considered approach, including an understandin...
Ten patients suffering from chronic premature ventricular complexes (>60/h) were treated orally in a...
Antiarrhythmic therapy is known to be associated with a significant risk of adverse cardiac reaction...
AbstractEighty-two patients with drug-resistant ventricular tachycardia or fibrillation were treated...
ObjectivesThis study evaluated the efficacy and safety of flecainide in addition to conventional dru...
Seventy-six patients with ventricular tachyarrhythmias (40 sustained and 36 nonsustained) were treat...
Importance: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially lethal gen...
The long-term efficacy and safety of flecainide (100 to 200 mg twice a day) were evaluated in 21 pat...
Over the last 35 years, flecainide proved itself one of the most commonly used arrhythmic drugs, exp...
AbstractThirty-eight patients who had inducible sustained ventricular tachycardia during baseline pr...
SUMMARY In a previous clinical study we demonstrated that tocainide is effective in the suppression ...
Flecainide has demonstrated unsurpassed antiarrhythmic activity in patients with stable ventricular ...
AbstractThe potential for proarrhythmic responses to the class IC sodium channel-blocking drugs enca...
Thirty-eight patients with organic heart disease and history of sudden cardiac arrest or recurrent s...
In the treatment of chronic ectopic atrial tachycardia, standard antiarrhythmic therapy has been sho...
Effective antiarrhythmic therapy requires a carefully considered approach, including an understandin...
Ten patients suffering from chronic premature ventricular complexes (>60/h) were treated orally in a...
Antiarrhythmic therapy is known to be associated with a significant risk of adverse cardiac reaction...
AbstractEighty-two patients with drug-resistant ventricular tachycardia or fibrillation were treated...
ObjectivesThis study evaluated the efficacy and safety of flecainide in addition to conventional dru...
Seventy-six patients with ventricular tachyarrhythmias (40 sustained and 36 nonsustained) were treat...
Importance: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially lethal gen...
The long-term efficacy and safety of flecainide (100 to 200 mg twice a day) were evaluated in 21 pat...
Over the last 35 years, flecainide proved itself one of the most commonly used arrhythmic drugs, exp...
AbstractThirty-eight patients who had inducible sustained ventricular tachycardia during baseline pr...
SUMMARY In a previous clinical study we demonstrated that tocainide is effective in the suppression ...